Literature DB >> 10627798

Using consensus OPCRIT diagnoses. An efficient procedure for best-estimate lifetime diagnoses.

M H Azevedo1, M J Soares, I Coelho, A Dourado, J Valente, A Macedo, M Pato, C Pato.   

Abstract

BACKGROUND: The Operational Criteria Checklist (OPCRIT) generates diagnoses according to 12 operational diagnostic systems (e.g. DSM-III, DSM-III-R, Research Diagnostic Criteria, ICD-10). AIMS: To examine the agreement between diagnoses generated by the OPCRIT, as completed by the interviewer, with a best-estimate lifetime procedure using the OPCRIT.
METHOD: Subjects came from large multi-generational bipolar or schizophrenia pedigrees (n = 100), and from a sample of unrelated subjects with schizophrenia (n = 40). We analysed the diagnostic agreement between OPCRIT diagnoses generated by the interviewer and our best-estimate OPCRIT diagnoses, according to DSM-III-R and ICD-10, using Cohen kappa statistics.
RESULTS: Excellent agreement was found between interviewer OPCRIT diagnoses and OPCRIT diagnoses made by the best-estimate lifetime consensus procedure for DSM-III-R (kappa = 0.83) and ICD-10 (kappa = 0.81).
CONCLUSIONS: Results suggest that this procedure for diagnostic assessment is an efficient alternative to classic best-estimate diagnosis procedures.

Entities:  

Mesh:

Year:  1999        PMID: 10627798     DOI: 10.1192/bjp.175.2.154

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  9 in total

1.  The genomic psychiatry cohort: partners in discovery.

Authors:  Michele T Pato; Janet L Sobell; Helena Medeiros; Colony Abbott; Brooke M Sklar; Peter F Buckley; Evelyn J Bromet; Michael A Escamilla; Ayman H Fanous; Douglas S Lehrer; Fabio Macciardi; Dolores Malaspina; Steve A McCarroll; Stephen R Marder; Jennifer Moran; Christopher P Morley; Humberto Nicolini; Diana O Perkins; Shaun M Purcell; Mark H Rapaport; Pamela Sklar; Jordan W Smoller; James A Knowles; Carlos N Pato
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-05-03       Impact factor: 3.568

2.  Food insecurity among people with severe mental disorder in a rural Ethiopian setting: a comparative, population-based study.

Authors:  K Tirfessa; C Lund; G Medhin; Y Hailemichael; A Fekadu; C Hanlon
Journal:  Epidemiol Psychiatr Sci       Date:  2017-11-16       Impact factor: 6.892

Review 3.  Competing definitions of schizophrenia: what can be learned from polydiagnostic studies?

Authors:  Lennart B Jansson; Josef Parnas
Journal:  Schizophr Bull       Date:  2006-12-08       Impact factor: 9.306

Review 4.  Clinical perspectives on the genetics of schizophrenia: a bottom-up orientation.

Authors:  Willem M A Verhoeven; Siegfried Tuinier
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

5.  Empathy in schizophrenia: impaired resonance.

Authors:  Helene Haker; Wulf Rössler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-04-18       Impact factor: 5.270

6.  DNA methylation age is not accelerated in brain or blood of subjects with schizophrenia.

Authors:  Brandon C McKinney; Huang Lin; Ying Ding; David A Lewis; Robert A Sweet
Journal:  Schizophr Res       Date:  2017-10-05       Impact factor: 4.939

Review 7.  A review of the reliability and validity of OPCRIT in relation to its use for the routine clinical assessment of mental health patients.

Authors:  Philip J Brittain; Daniel Stahl; James Rucker; Jamie Kawadler; Gunter Schumann
Journal:  Int J Methods Psychiatr Res       Date:  2013-05-09       Impact factor: 4.035

8.  Psychosocial markers of age at onset in bipolar disorder: a machine learning approach.

Authors:  Sorcha Bolton; Dan W Joyce; Katherine Gordon-Smith; Lisa Jones; Ian Jones; John Geddes; Kate E A Saunders
Journal:  BJPsych Open       Date:  2022-07-18

9.  Do symptom dimensions or categorical diagnoses best discriminate between known risk factors for psychosis?

Authors:  Judith Allardyce; Robin G McCreadie; Gary Morrison; Jim van Os
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-05-14       Impact factor: 4.328

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.